The Type 1 Angiotensin II Receptor pipeline drugs market research report outlays comprehensive information on the Type 1 Angiotensin II Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Type 1 Angiotensin II Receptor pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Cardiovascular, Metabolic Disorders, Genito Urinary System, and Central Nervous System which include the indications Idiopathic (Essential) Hypertension, Hypertension, Dyslipidemia, Hyperlipidemia, Chronic Kidney Disease (Chronic Renal Failure), Focal Segmental Glomerulosclerosis (FSGS), Traumatic Brain Injury, and Insomnia. It also reviews key players involved in Type 1 Angiotensin II Receptor targeted therapeutics development with respective active and dormant or discontinued products.
The Type 1 Angiotensin II Receptor pipeline targets constitutes close to 45 molecules. Out of which, approximately 42 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Phase III, Phase II, Phase I, IND/ CTA Filed, and Preclinical stages are 5, 15, 5, 7, 1, and 9 respectively. Similarly, the universities portfolio in Preclinical, and Discovery comprises 2, and 1 molecule.
Type 1 Angiotensin II Receptor overview
Angiotensin II receptor type 1 (AT1R) is a G protein-coupled receptor (GPCR) that plays a crucial role in the renin-angiotensin system (RAS), a complex hormonal pathway that regulates blood pressure, fluid balance, and electrolyte homeostasis. AT1R is the primary mediator of the biological actions of angiotensin II (Ang II), a potent vasoconstrictor and proinflammatory peptide.
For a complete picture of Type 1 Angiotensin II Receptor’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.